Real-World Study of Adjuvant Biosimilar Trastuzumab-dkst for HER2-Positive Breast Cancer Treatment in a Brazilian Population.

Debora de Melo Gagliato Tomás Reinert Cláudio Rocha Monique Celeste Tavares Sâmio Pimentel William Fuzita Márcia Araújo Danielli Matias Sabina Aleixo Bruno França Érida Magaton Natália Brito Ana Carolina Ferreira Cardoso Vivienne Carduz Castilho

Published in: Oncology and therapy (2024)

NCT03892655.

Keyphrases